The 7 analysts offering 12-month price forecasts for Ligand Pharmaceuticals Inc have a median target of 190.00, with a high estimate of 310.00 and a low estimate of 170.00. The median estimate represents a +38.30% increase from the last price of 137.38.
The current consensus among 7 polled investment analysts is to Buy stock in Ligand Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.04
Reporting Date Nov 11
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.